Literature DB >> 6127788

Effect of cholinergic, adrenergic, and dopaminergic blockade on gastrin secretion in healthy subjects.

E Schrumpf, P Linnestad.   

Abstract

The effects of receptor blockers on the cholinergic, adrenergic, and dopaminergic nervous system have been tested on basal and meal-stimulated gastrin secretion in six normal subjects. Basal gastrin secretion was unaffected by all agents, as was gastrin secretion after food when alpha- and beta-adrenergic blockers were applied. Both atropine and haloperidol significantly enhanced the meal-induced secretion of gastrin. Dopamine had no effect on gastrin secretion. It is suggested that this effect of haloperidol is mediated by blockade of dopaminergic receptors, supporting the idea that the dopaminergic nervous system may influence gastrin secretion. It is concluded that the adrenergic nervous system does not influence gastrin secretion under physiological conditions, whereas both cholinergic and dopaminergic receptors may play an inhibitory role.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6127788     DOI: 10.3109/00365528209181040

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  3 in total

1.  Effect of L-dopa with and without inhibition of extra cerebral dopa decarboxylase on gastric acid secretion and gastrin release in man.

Authors:  R Caldara; C Barbieri; V Piepoli; M Borzio; E Masci
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

2.  Dopaminergic control of gastric acid and gastrin secretion in man: lack of effects after acute oral administration of ibopamine, an analogue of dopamine.

Authors:  R Caldara; E Masci; C Barbieri; M Cambielli; C Ferrari; A Tittobello
Journal:  Br J Clin Pharmacol       Date:  1983-07       Impact factor: 4.335

3.  Effects of dopamine receptor antagonists on gastrin and vomiting responses to apomorphine.

Authors:  M Goiny; K Uvnäs-Moberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.